Kerafast launched in late 2011 as a spin out of Keranetics in Winston-Salem, North Carolina. Our headquarters is now located in the innovation district of Boston’s Seaport. The Kerafast team is composed of experienced scientists, businessmen and women who are committed to life science research. Nearly 50% of our team have a PhD, MBA or MS and senior leadership have all started and successfully exited several companies in the life science industry. Many of our employees mentor, volunteer and sit on non-profit boards.
As one of the founders of Kerafast and its unique business model, Bill brings over 35 years’ experience in senior management positions with life science research tools companies. Most recently he co-founded and was President of Maine Manufacturing, LLC, global specialists in research products manufacturing, taking it from 3 employees to over 200 in a 6-year period. Bill’s previous roles include CEO of London-based Whatman plc, President of the Life Sciences Division of Millipore Corporation, NA President of Proteome Systems, and President of Amicon. He earned his BS in Biomedical Engineering from Duke University.
In her work roles, Jen enjoys merging her scientific background with business planning and strategy. With a BS/MS from Ohio University and a PhD from Brown University, Jen has held roles at Cohesive Technologies (now part of ThermoFisher), Qiagen, BioTrove (acquired by Life Technologies) and Biocius (now part of Agilent). Jen is President of a non-profit organization, the CMA, which supports 1,500 families in her downtown Boston neighborhood of Charlestown. She also supports several canine rescue groups, enjoys being a mentor and is Trustee of the USS Constitution Museum.
One of Kerafast's longest-tenured employees, Travis started with the company as an intern. He completed his bachelor's degree at the University of Kansas and his PhD and MBA at Wake Forest University, specializing in biochemistry and structural biology of proteins involved in genetic kidney diseases. Travis is passionate about open access to research materials and open access scientific publications, aiding in the acceleration of scientific discovery and sharing of research developments. He is also a supporter of the Oxalosis and Hyperoxaluria Foundation (OHF).